Thyrocare Technologies Limited (BOM:539871)
534.40
+0.05 (0.01%)
At close: Oct 1, 2026
Thyrocare Technologies Market Cap
Thyrocare Technologies has a market cap or net worth of 85.06 billion as of October 2, 2026. Its market cap has increased by 38.35% in one year.
Market Cap
85.06B
Enterprise Value
83.67B
Revenue
8.76B
Ranking
n/a
PE Ratio
48.38
Stock Price
534.40
ChartMarket Cap Chart
Since May 9, 2016, Thyrocare Technologies's market cap has increased from 33.20B to 85.06B, an increase of 156.19%. That is a compound annual growth rate of 9.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 85.06B | 19.82% |
| Dec 31, 2025 | 70.99B | 46.48% |
| Dec 31, 2024 | 48.46B | 42.22% |
| Dec 29, 2023 | 34.08B | 4.19% |
| Dec 30, 2022 | 32.71B | -44.08% |
| Dec 31, 2021 | 58.49B | 21.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| One Global Service Provider | 10.33B |
| Chandan Healthcare | 5.69B |
| Pramodini Medicare | 2.61B |
| Aspira Pathlab & Diagnostics | 1.42B |
| Star Imaging and Path Lab | 1.34B |
| Modern Diagnostic & Research Centre | 1.11B |
| Invicta Diagnostic | 848.61M |
| Family Care Hospitals | 99.93M |